Project Description

CEO: Jurgi Camblong

Sector: Genomics
Location: Switzerland (Saint-Sulpice), Boston MA (USA)
Investment Stage: Growth
Investment Status: Current
Year Invested: 2020


SOPHiA GENETICS is a health tech company democratizing Data-Driven Medicine to improve health outcomes and economics worldwide. By unlocking the power of new-generation health data for cancer and rare diseases management, the universal SOPHiA Platform allows clinical researchers to act with precision and confidence. The company’s innovative approach enables an ever-expanding community of over 1,000 institutions to benefit from knowledge sharing, fostering a new era in healthcare. SOPHiA’s achievement is recognized by the MIT Technology Review’s “50 Smartest Companies”.

See SOPHiA GENETICS related news here

Back to all companies

Endeavour Vision
Board Observer

Fernando Pacheco

Endeavour Vision
Deal Team

Damien Tappy
Fernando Pacheco